TARGETING TRANSCRIPTIONAL ADDICTION FOR GBM THERAPY THROUGH CDK7 INHIBITION

被引：0

作者：

Meng, Wei ^{[1
]}

Wang, Jiajia ^{[1
]}

Li, Qifeng ^{[1
]}

Liu, Fang ^{[2
]}

Li, Meng ^{[2
]}

Jiang, Wenyan ^{[2
]}

Lin, Li ^{[3
]}

Dai, Xiaomin ^{[3
,4
]}

Wang, Hongxiang ^{[5
]}

Zhang, Chenran ^{[1
]}

Wang, Baocheng ^{[1
]}

Chen, Juxiang ^{[5
]}

Zhang, Liye ^{[3
]}

Tang, Yujie ^{[1
,2
]}

Ma, Jie ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Pediat Neurosurg, Shanghai, Peoples R China

[2] Shanghai Jiao Tong Univ, Sch Med, Key Lab Cell Differentiat & Apoptosis, Natl Minist Educ,Dept Pathophysiol, Shanghai, Peoples R China

[3] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China

[4] Univ Chinese Acad Sci, Beijing, Peoples R China

[5] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China

来源：

NEURO-ONCOLOGY | 2018年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TBIO-01

引用

页码：180 / 180

页数：1

共 50 条

[41] THZ1 targeting CDK7 suppresses c-KIT transcriptional activity in gastrointestinal stromal tumours
Jianyi Sun
Qiang Zhang
Xiangfei Sun
Anwei Xue
Xiaodong Gao
Kuntang Shen
Cell Communication and Signaling, 20
[42] Targeting CDK7 reverses tamoxifen resistance through regulating stemness in ER+ breast cancer
Yasmin M. Attia
Salama A. Salama
Samia A. Shouman
Cristina Ivan
Abdelrahman M. Elsayed
Paola Amero
Cristian Rodriguez-Aguayo
Gabriel Lopez-Berestein
Pharmacological Reports, 2022, 74 : 366 - 378
[43] Transcriptional inhibition by CDK7/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma (vol 18, 140, 2019)
Zhang, Jing
Liu, Shenglan
Ye, Qianyun
Pan, Jingxuan
MOLECULAR CANCER, 2021, 20 (01)
[44] Targeting CDK7 reverses tamoxifen resistance through regulating stemness in ER plus breast cancer
Attia, Yasmin M.
Salama, Salama A.
Shouman, Samia A.
Ivan, Cristina
Elsayed, Abdelrahman M.
Amero, Paola
Rodriguez-Aguayo, Cristian
Lopez-Berestein, Gabriel
PHARMACOLOGICAL REPORTS, 2022, 74 (02) : 366 - 378
[45] Preclinical Efficacy and Molecular Mechanism of Targeting CDK7-Dependent Transcriptional Addiction in Ovarian Cancer
Zhang, Zhenfeng
Peng, Huixin
Wang, Xiaojie
Yin, Xia
Ma, Pengfei
Jing, Ying
Cai, Mei-Chun
Liu, Jin
Zhang, Meiying
Zhang, Shengzhe
Shi, Kaixuan
Gao, Wei-Qiang
Di, Wen
Zhuang, Guanglei
MOLECULAR CANCER THERAPEUTICS, 2017, 16 (09) : 1739 - 1750
[46] THZ1 targeting CDK7 suppresses c-KIT transcriptional activity in gastrointestinal stromal tumours
Sun, Jianyi
Zhang, Qiang
Sun, Xiangfei
Xue, Anwei
Gao, Xiaodong
Shen, Kuntang
CELL COMMUNICATION AND SIGNALING, 2022, 20 (01)
[47] Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models
Minzel, Waleed
Venkatachalam, Avanthika
Fink, Avner
Hung, Eric
Brachya, Guy
Burstain, Ido
Shaham, Maya
Rivlin, Amitai
Omer, Itay
Zinger, Adar
Elias, Shlomo
Winter, Eitan
Erdman, Paul E.
Sullivan, Robert W.
Fung, Leah
Mercurio, Frank
Li, Dansu
Vacca, Joseph
Kaushansky, Nathali
Shlush, Liran
Oren, Moshe
Levine, Ross
Pikarsky, Eli
Snir-Alkalay, Irit
Ben-Neriah, Yinon
CELL, 2018, 175 (01) : 171 - +
[48] Simultaneous targeting of the cell cycle and transcription through irreversible inhibition of CDK7: a novel, new therapeutic approach for high-grade glioma
Greenall, Sameer
Johns, Terrance G.
CANCER RESEARCH, 2016, 76
[49] Inhibition Of Cdk7 Attenuates Doxorubicin Cardiotoxicity And Enhances Anticancer Efficacy
Chen, Jingrui
Wei, Jing
Xia, Peng
Liu, Yuening
Cheng, Zhaokang
CIRCULATION RESEARCH, 2023, 133
[50] CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success?
Diab, Sarah
Yu, Mingfeng
Wang, Shudong
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (14) : 7458 - 7474

← 1 2 3 4 5 →